Robert Alber

I am proud to represent with Creapure the #1 premium creatine product in sports nutrition and the only Creatine produced outside China – simply the best product you can get!
With our new creatine product Creavitalis we are serving the health and food industry.
In food, creatine fortifies low meat diets and helps to increase protein bioavailability, furtherly it is interesting as functional food ingredient.
In health, creatine has a broad range of benefits, thanks to its central role in the cellular energy metabolism. Numerous solid studies and two EU health claims prove benefits in various applications, such as sarcopenia, post viral fatigue (ME/CFS, Long Covid), women’s health, male fertility, longevity, cardiovascular, cognitive function, or special nutrition.

With over 14 years of work experience in the chemical and nutrition industries, I am a versatile and strategic leader who drives innovation and growth for Alzchem. As the VP of Human Nutrition, I oversee the development and implementation of the global strategy for the company’s portfolio of products and services in the health and wellness sector. I also manage key accounts, partnerships, and new business opportunities, leveraging my skills in new business development, key account management, and strategy. Previously, I was the VP of Animal Nutrition, where I led the launch and expansion of a novel technology that increased the performance and lowered the costs of animal feed customers. I also have an extensive background in consulting, having served as the Managing Director of ACTO Growth Partners, a strategy implementation firm that focuses on delivering results for clients in various industries. As part of my mission, I aim to create value and impact for Alzchem and its customers, while also contributing to the advancement of nutrition and chemistry as fields of expertise. I am passionate about finding innovative solutions to complex challenges, collaborating with diverse and talented teams, and supporting the company’s vision and culture.